decision-making tool Press Release

Title Picture
07/27/2018 - 09:31
Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
07/17/2018 - 17:12
Purdue Extension to host Crops Field Day on Sept. 6
Purdue's picture
Purdue
07/01/2018 - 21:49
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
07/01/2018 - 20:07
Bavarian Research Foundation funds seven projects with TUM involvement
Technical University of Munich's picture
Technical Unive...
06/13/2018 - 12:21
Students Propose Ways To Reduce Lead Levels in Homes
CarnegieMellon's picture
CarnegieMellon
05/25/2018 - 02:08
Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable Stage III non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
05/15/2018 - 07:00
CMU's Qian Drives Big Data To Improve Transportation Systems
CarnegieMellon's picture
CarnegieMellon
04/23/2018 - 23:36
AstraZeneca reports results from the ARCTIC trial in third-line non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
03/10/2018 - 23:57
AstraZeneca provides update on MYSTIC trial timeline
AstraZeneca's picture
AstraZeneca
02/17/2018 - 11:06
US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
02/14/2018 - 16:04
Honeywells Enhanced Building Technology Offers New Interfaces To Help Improve Data Visualization And Decision-Making
Honeywell International's picture
Honeywell Inter...
10/31/2017 - 02:57
AstraZeneca and Incyte enter clinical trial collaboration in early lung cancer
AstraZeneca's picture
AstraZeneca
10/17/2017 - 03:26
US FDA accepts supplemental Biologics License Application for Imfinzi in locally advanced unresectable non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
10/08/2017 - 21:37
The European Medicines Agency accepts marketing authorisation application for Imfinzi in locally-advanced unresectable non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
09/12/2017 - 08:25
VIMS teams up to demo new coastal-mapping technologies
VIMS's picture
VIMS
09/08/2017 - 16:36
AstraZeneca presents superior progression-free survival for Imfinzi in the PACIFIC trial of patients with locally-advanced unresectable lung cancer at ESMO 2017 Congress
AstraZeneca's picture
AstraZeneca
07/28/2017 - 13:08
MN Aquatic Invasive Species Research Center announces six new projects
UniversityofMinnesota's picture
UniversityofMin...
07/27/2017 - 01:45
AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer
AstraZeneca's picture
AstraZeneca
05/29/2017 - 10:01
Database aims to personalize chemotherapy and reduce long-term heart risks
University of Alberta's picture
University of A...
05/18/2017 - 09:38
The Promising Impact of Prescription Drug Monitoring Programs
SAMHSA's picture
SAMHSA
05/11/2017 - 23:43
Imfinzi significantly reduces the risk of disease worsening or death in the Phase III PACIFIC trial for Stage III unresectable lung cancer
AstraZeneca's picture
AstraZeneca
05/01/2017 - 00:36
AstraZenecas Imfinzi (durvalumab) receives US FDA accelerated approval for previously treated patients with advanced bladder cancer
AstraZeneca's picture
AstraZeneca
04/24/2017 - 02:49
Smart City: Swisscom and IMD partner again to help cities digitize
Swisscom's picture
Swisscom
02/17/2017 - 12:52
Updated durvalumab monotherapy data confirm results in urothelial bladder cancer
AstraZeneca's picture
AstraZeneca
01/17/2017 - 03:00
AstraZeneca expands 1st-line lung cancer Immuno-Oncology programme opportunities
AstraZeneca's picture
AstraZeneca
12/09/2016 - 09:57
US FDA accepts first biologics license application for AstraZenecas durvalumab in bladder cancer
AstraZeneca's picture
AstraZeneca
10/10/2016 - 03:39
Durvalumab shows promising preliminary early data in lung and head & neck cancers
AstraZeneca's picture
AstraZeneca
09/29/2016 - 15:40
Making smarter decisions about classroom technologies
MIT's picture
MIT
09/19/2016 - 01:29
IQN to Share Best Practices, Showcase Predictive Analytics & Introduce New Features at Contingent Workforce events in Las Vegas
IQNavigator's picture
IQNavigator
06/05/2016 - 02:16
Durvalumab monotherapy demonstrates efficacy in urothelial bladder cancer
AstraZeneca's picture
AstraZeneca
05/18/2016 - 11:48
Rockefeller Foundation & Arup Debut a Pioneering Tool that Allows Cities to Better Understand Their Capacity to Address Social, Physical, or Economic Challenges
Rockefeller Foundation's picture
Rockefeller Fou...
03/13/2016 - 12:54
Glad youre listening: SIMBA study brings patients voices to the fore
Group Health's picture
Group Health